Cargando…
Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models
Autores principales: | Lam, Sze-Kwan, Mutsaers, Steven Eugene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486835/ https://www.ncbi.nlm.nih.gov/pubmed/36147341 http://dx.doi.org/10.3389/fphar.2022.1015959 |
Ejemplares similares
-
Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo
por: Lam, Sze-Kwan, et al.
Publicado: (2022) -
Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma
por: Lapidot, Moshe, et al.
Publicado: (2022) -
Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural Mesothelioma
por: Sato, Yuzo, et al.
Publicado: (2021) -
Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma Cells
por: Sato, Yuzo, et al.
Publicado: (2018) -
MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
por: Birnie, Kimberly A., et al.
Publicado: (2019)